Citation: C. Barbui et S. Garattini, STUDI CLINICI CONTROLLATI E NUOVI PSICOFARMACI: ALCUNE CONSIDERAZIONI DI METODO, Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali Archivio italiano per le malattie nervose e mentali. Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali , CXXIII(1), 1999, pp. 1-9
Citation: S. Garattini et al., ANTIDEPRESSANT AGENTS - FROM TRICYCLICS TO SEROTONIN UPTAKE INHIBITORS, Psychological medicine, 28(5), 1998, pp. 1169-1178
Citation: C. Barbui et al., A CROSS-SECTIONAL AUDIT OF BENZODIAZEPINE USE AMONG GENERAL-PRACTICE PATIENTS, Acta psychiatrica Scandinavica, 97(2), 1998, pp. 153-156
Citation: C. Barbui et B. Saraceno, LOW-DOSE NEUROLEPTIC THERAPY AND EXTRAPYRAMIDAL SIDE-EFFECTS IN SCHIZOPHRENIA - AN EFFECT SIZE ANALYSIS, European psychiatry, 11(8), 1996, pp. 412-415
Authors:
BARBUI C
SARACENO B
LIBERATI A
GARATTINI S
Citation: C. Barbui et al., LOW-DOSE NEUROLEPTIC THERAPY AND RELAPSE IN SCHIZOPHRENIA - METAANALYSIS OF RANDOMIZED CONTROLLED TRIALS, European psychiatry, 11(6), 1996, pp. 306-313
Authors:
OSTERMANN D
PERICO N
IMBERTI O
BARBUI C
BONTEMPELLI M
REMUZZI G
Citation: D. Ostermann et al., COLCHICINE ALLOWS PROLONGED SURVIVAL OF HIGHLY REACTIVE RENAL-ALLOGRAFT IN THE RAT, Journal of the American Society of Nephrology, 4(6), 1993, pp. 1294-1299